These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 2565819

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA, Bush LG, Gibb JW, Hanson GR.
    Brain Res; 1992 Feb 07; 571(2):260-4. PubMed ID: 1351780
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain.
    Merchant KM, Bush LG, Gibb JW, Hanson GR.
    Brain Res; 1989 Oct 23; 500(1-2):21-9. PubMed ID: 2532557
    [Abstract] [Full Text] [Related]

  • 5. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 23; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 6. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
    Barnes JM, Barnes NM, Costall B, Naylor RJ.
    Neuropharmacology; 1990 Apr 23; 29(4):327-36. PubMed ID: 1971430
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist.
    White FJ.
    Eur J Pharmacol; 1987 Mar 03; 135(1):101-5. PubMed ID: 3494620
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.
    Stoof JC, Verheijden PF, Leysen JE.
    Brain Res; 1987 Oct 13; 423(1-2):364-8. PubMed ID: 2823991
    [Abstract] [Full Text] [Related]

  • 10. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 13; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 11. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
    Kelly E, Nahorski SR.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May 13; 335(5):508-12. PubMed ID: 2441268
    [Abstract] [Full Text] [Related]

  • 12. Dissimilarities between cholinergic and dopaminergic turning elicited by nucleus accumbens stimulation in freely moving rats.
    Saigusa T, Koshikawa N, Kitamura M, Mizutani K, Kobayashi M, Cools AR.
    Eur J Pharmacol; 1995 Feb 14; 274(1-3):213-20. PubMed ID: 7539377
    [Abstract] [Full Text] [Related]

  • 13. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

  • 14. Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens.
    White FJ, Wang RY.
    J Neurosci; 1986 Jan 07; 6(1):274-80. PubMed ID: 2868077
    [Abstract] [Full Text] [Related]

  • 15. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum.
    Zhang X, Segawa T.
    Jpn J Pharmacol; 1989 Jul 07; 50(3):333-45. PubMed ID: 2569545
    [Abstract] [Full Text] [Related]

  • 16. Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study.
    Hu XT, Wang RY.
    J Neurosci; 1988 Nov 07; 8(11):4340-8. PubMed ID: 2972814
    [Abstract] [Full Text] [Related]

  • 17. Evidence that the stimulatory effect of neurotensin on dopamine release in rat nucleus accumbens slices is independent of dopamine D2-receptor activation.
    Reyneke L, Russell VA, Taljaard JJ.
    Brain Res; 1990 Nov 26; 534(1-2):188-94. PubMed ID: 1981481
    [Abstract] [Full Text] [Related]

  • 18. Anticonvulsant effects of ipsilateral but not contralateral microinjections of the dopamine D2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats.
    Wahnschaffe U, Löscher W.
    Brain Res; 1991 Jul 12; 553(2):181-7. PubMed ID: 1681980
    [Abstract] [Full Text] [Related]

  • 19. Apomorphine affects cholecystokinin content via preferentially D1 or D2 dopamine receptor according to the regions of the rat brain.
    Yoshikawa T, Fukamauchi F, Shibuya H, Takahashi R.
    Neuropeptides; 1989 Jul 12; 13(2):103-5. PubMed ID: 2567971
    [Abstract] [Full Text] [Related]

  • 20. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
    Merchant KM, Bush LG, Gibb JW, Hanson GR.
    J Pharmacol Exp Ther; 1990 Nov 12; 255(2):775-80. PubMed ID: 2147039
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.